Form 4: Bio-Key International Executive Acquires Shares Under Employee Stock Purchase Plan

Mira LaCous, Chief Technology Officer of Bio-Key International, acquired 139 shares of common stock under the company's Employee Stock Purchase Plan on December 31, 2024.

Summary

• On December 31, 2024, Mira LaCous, the Chief Technology Officer of Bio-Key International, acquired 139 shares of common stock.
• The shares were purchased under the company's 2021 Employee Stock Purchase Plan at a price of $1.4 per share.
• Following the transaction, LaCous directly owns 10,619 shares of Bio-Key International.
• All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
• Holdings do not include options to purchase 174 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction under an employee stock purchase plan. The executive's participation is a mildly positive signal, but the transaction itself is not significant enough to drastically alter sentiment.

Positives

• An executive's participation in the Employee Stock Purchase Plan can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company. It is common for executives to participate in employee stock purchase plans.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders. It provides transparency to shareholders regarding executive stock ownership.

Key Dates

Keywords

Bio-Key International, BKYI, Mira LaCous, Employee Stock Purchase Plan, Stock Acquisition, Form 4, Reverse Stock Split, Chief Technology Officer